Login / Signup
Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series.
Kent Doi
Mahoko Ikeda
Naoki Hayase
Kyoji Moriya
Naoto Morimura
null null
Published in:
Critical care (London, England) (2020)
Keyphrases
</>
end stage renal disease
coronavirus disease
ejection fraction
sars cov
newly diagnosed
prognostic factors